Oppenheimer Asset Management »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Oppenheimer Asset Management

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Oppenheimer Asset Management from 13F filings

Historical chart of Oppenheimer Asset Management investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Oppenheimer Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Oppenheimer Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $209k 176k 1.19
2024-06-30 $207k 186k 1.11
2024-03-31 $105k 108k 0.97
2023-09-30 $185k 198k 0.93

More positions owned by Oppenheimer Asset Management

Microsoft Corporation (MSFT)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Amazon (AMZN)
Goldman Sachs Etf Tr Acces Treasury (GBIL)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
NVIDIA Corporation (NVDA)
Chevron Corporation (CVX)
Johnson & Johnson (JNJ)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Raytheon Technologies Corp (RTX)
Servicenow (NOW)
Citigroup Com New (C)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Oppenheimer Asset Management

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1